LON:MTPH

Midatech Pharma plc (MTPH.L) Share Forecast, Price & News

GBX 32.50

-0.50 (-1.52 %)

(As of 01/18/2021 09:00 PM ET)

Add

Compare

Today's Range

31.50

Now: GBX 32.50▼

50-Day Range

MA: GBX 27.10▼

52-Week Range

Now: GBX 32.50▼

Volume304,020 shs

Average Volume388,810 shs

Market Capitalization£20.50 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTD201, a long acting dose of Octreotide for the treatment of acromegaly and neuroendocrine tumors; and MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma. It also offers drug delivery platforms, such as Q-Sphera, a microencapsulation and polymer-depot sustained release drug delivery platform; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. Midatech Pharma plc was founded in 2000 and is headquartered in Cardiff, the United Kingdom.

MarketRank^™

Overall MarketRank^™

0.66 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Midatech Pharma plc (MTPH.L).

3.3 Community Rank

Outperform Votes
Midatech Pharma plc (MTPH.L) has received 242 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Midatech Pharma plc (MTPH.L) has received 125 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Midatech Pharma plc (MTPH.L) has received 65.94% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Midatech Pharma plc (MTPH.L) and other stocks. Vote “Outperform” if you believe MTPH will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MTPH will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Midatech Pharma plc (MTPH.L) does not currently pay a dividend.
Dividend Growth
Midatech Pharma plc (MTPH.L) does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Midatech Pharma plc (MTPH.L) insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Midatech Pharma plc (MTPH.L) is -0.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Midatech Pharma plc (MTPH.L) is -0.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Midatech Pharma plc (MTPH.L) has a P/B Ratio of 2.72. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange LON

Industry Biotechnology

Sub-IndustryN/A

SectorMedical

Current SymbolLON:MTPH

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.midatechpharma.com

Phone+44-1235-841575

Employees65

Debt

Debt-to-Equity Ratio77.15

Current Ratio1.40

Quick Ratio1.40

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales£390,000.00

Price / Sales52.56

Cash FlowGBX 10.83 per share

Price / Cash Flow3.00

Book ValueGBX 11.60 per share

Price / Book2.80

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares63,073,900

Market Cap£20.50 million

Next Earnings DateN/A

OptionableNot Optionable

GBX 32.50

-0.50 (-1.52 %)

(As of 01/18/2021 09:00 PM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive MTPH News and Ratings via Email

Sign-up to receive the latest news and ratings for MTPH and its competitors with MarketBeat's FREE daily newsletter.

Midatech Pharma plc (MTPH.L) (LON:MTPH) Frequently Asked Questions

How has Midatech Pharma plc (MTPH.L)'s stock price been impacted by Coronavirus (COVID-19)?

Midatech Pharma plc (MTPH.L)'s stock was trading at GBX 36 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, MTPH shares have decreased by 12.5% and is now trading at GBX 31.50.
View which stocks have been most impacted by COVID-19.

What stocks does MarketBeat like better than Midatech Pharma plc (MTPH.L)?

Wall Street analysts have given Midatech Pharma plc (MTPH.L) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Midatech Pharma plc (MTPH.L) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Midatech Pharma plc (MTPH.L)'s earnings last quarter?

Midatech Pharma plc (MTPH.L) (LON:MTPH) issued its earnings results on Thursday, September, 10th. The company reported ($64.00) earnings per share (EPS) for the quarter.
View Midatech Pharma plc (MTPH.L)'s earnings history.

Who are some of Midatech Pharma plc (MTPH.L)'s key competitors?

Some companies that are related to Midatech Pharma plc (MTPH.L) include Novoheart (NVH), OKYO Pharma Limited (OKYO.L) (OKYO), ReNeuron Group plc (RENE.L) (RENE), C4X Discovery Holdings plc (C4XD.L) (C4XD), Destiny Pharma plc (DEST.L) (DEST), Oxford BioDynamics Plc (OBD.L) (OBD), Agronomics Limited (ANIC.L) (ANIC), Pediapharm Inc. (PDP.V) (PDP), Sirona Biochem Corp. (SBM.V) (SBM), OptiBiotix Health Plc (OPTI.L) (OPTI), SkinBioTherapeutics Plc (SBTX.L) (SBTX), Microbix Biosystems Inc. (MBX.TO) (MBX), Hvivo (HVO), IXICO plc (IXI.L) (IXI) and Covalon Technologies Ltd. (COV.V) (COV).
View all of MTPH's competitors.

What other stocks do shareholders of Midatech Pharma plc (MTPH.L) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Midatech Pharma plc (MTPH.L) investors own include Aldeyra Therapeutics (ALDX), Barclays PLC (BARC.L) (BARC), Telefonaktiebolaget LM Ericsson (publ) (ERIC), Futura Medical plc (FUM.L) (FUM), Lloyds Banking Group plc (LLOY.L) (LLOY), Midatech Pharma (MTP), Intec Pharma (NTEC), Pearson plc (PSON.L) (PSON), Royal Mail plc (RMG.L) (RMG) and AON (AON).

Who are Midatech Pharma plc (MTPH.L)'s key executives?

Midatech Pharma plc (MTPH.L)'s management team includes the following people:

Mr. Stephen A. Stamp, CEO, CFO & Director (Age 58, Pay $171.18k)
Dr. Tim Sparey Ph.D., Chief Bus. Officer
Mr. Justin Barry BSc (Hons.), MBIOL, CBIOL, QP, Head of Manufacturing
Dr. Steve Damment, Exec. VP of R&D (Age 62)
Mr. David Benharris, Pres of Midatech Pharma US Inc (Age 55)

What is Midatech Pharma plc (MTPH.L)'s stock symbol?

Midatech Pharma plc (MTPH.L) trades on the London Stock Exchange (LON) under the ticker symbol "MTPH."

How do I buy shares of Midatech Pharma plc (MTPH.L)?

Shares of MTPH and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Midatech Pharma plc (MTPH.L)'s stock price today?

One share of MTPH stock can currently be purchased for approximately GBX 31.50.

How big of a company is Midatech Pharma plc (MTPH.L)?

Midatech Pharma plc (MTPH.L) has a market capitalization of £19.87 million and generates £390,000.00 in revenue each year. Midatech Pharma plc (MTPH.L) employs 65 workers across the globe.

What is Midatech Pharma plc (MTPH.L)'s official website?

The official website for Midatech Pharma plc (MTPH.L) is www.midatechpharma.com.

How can I contact Midatech Pharma plc (MTPH.L)?

Midatech Pharma plc (MTPH.L)'s mailing address is 65 Innovation Drive, Milton Park, ABINGDON, OX14 4RQ, United Kingdom. The company can be reached via phone at +44-1235-841575.

This page was last updated on 1/19/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Midatech Pharma plc (MTPH.L) Share Forecast, Price & News

Adding

Adding

Adding Midatech Pharma plc (MTPH.L)

MarketRank™

Overall MarketRank™